Researcher.Life Logo

Egyptian Rheumatologist : Impact Factor & More

eISSN: 2090-2433pISSN: 1110-1164
JournalOpen Access

Key Metrics

CiteScore
2
H-Index
19
SJR
Q4Rheumatology
SNIP
0.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Egyptian Rheumatologist Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Quarterly
Publication Time39
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEgyptian Society of Rheumatic Diseases
FrequencyQuarterly
Publication Start Year1977
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 39
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Egyptian Rheumatologist ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Egyptian Rheumatologist

Linking inflammatory pathways to nutritional interventions in systemic lupus erythematosus (SLE): Toward a context-specific nutritional framework
  • 1 Jun 2026
  • The Egyptian Rheumatologist
Role of urinary biomarkers in the diagnosis of lupus cystitis in systemic lupus erythematosus patients: Relation to disease activity and lower urinary tract manifestations
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Assessment of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus and its association with disease activity, functional status, pain severity and depression
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease
  • 1 Apr 2026
  • The Egyptian Rheumatologist
The potential role of neutrophil, eosinophil, and platelet to lymphocyte ratios in the assessment of disease activity in systemic lupus erythematosus patients
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Linking inflammatory pathways to nutritional interventions in systemic lupus erythematosus (SLE): Toward a context-specific nutritional framework
  • 1 Jun 2026
  • The Egyptian Rheumatologist
Role of urinary biomarkers in the diagnosis of lupus cystitis in systemic lupus erythematosus patients: Relation to disease activity and lower urinary tract manifestations
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Assessment of kinesiophobia in patients with rheumatoid arthritis and systemic lupus erythematosus and its association with disease activity, functional status, pain severity and depression
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin
  • 1 Apr 2026
  • The Egyptian Rheumatologist
Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease
  • 1 Apr 2026
  • The Egyptian Rheumatologist
The potential role of neutrophil, eosinophil, and platelet to lymphocyte ratios in the assessment of disease activity in systemic lupus erythematosus patients
  • 1 Apr 2026
  • The Egyptian Rheumatologist

FAQs on Egyptian Rheumatologist